GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
GPCR alterations were found to significantly correlate with TMB across the cohort of 4,787 melanomas, supporting this potential finding in the limited LMN subset.
All 10 tumors had low (less than or equal to 2 mutations/Megabase) TMB indicating a potential trend between G protein-coupled receptor (GPCR) alterations and low TMB in LMNs.